Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited, and Hong Kong Securities Clearing Company Limited disclaim responsibility for the contents of the White Form of Share Offer Acceptance, stating no representation as to its accuracy or completeness. This follows the composite offer and response document dated 12 February 2026 jointly issued by WuXi XDC Cayman Inc. (the “Offeror”) and BioDlink International Company Limited (the “Company,” stock code: 1875).

According to the announcement, the White Form of Share Offer Acceptance and Transfer is provided for holders of the Company’s ordinary shares who wish to accept the offer. The consideration offered is HK$4.00 in cash per share. Holders must complete the necessary form and ensure all relevant documents—such as share certificates—are submitted to the designated share registrar, Tricor Investor Services Limited, by the stated deadline. The offer includes provisions concerning overseas shareholders, who are advised to assess local regulatory requirements before accepting the share offer.

WuXi XDC Cayman Inc. is named as the “Transferee,” while the Company’s shareholders are identified as “Transferor(s).” All shares tendered under the offer must be free from liens and unencumbered. The announcement reiterates the importance of adhering to the formalities listed in the form, confirming that submission of incomplete or inaccurate details may result in invalidation of the acceptance.